Emna Ben Khlifa

Dr. Emna Ben Khlifa

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 December 2023 in Cellular and Molecular Life Sciences
Verified
Journal Article
Closed access
PDF file
ADAndrea Denardo
Andrea Denardo
EKEmna Ben Khlifa
Emna Ben Khlifa
MBMattia Bignotti
Mattia Bignotti
RGRoberta Giuliani
Roberta Giuliani
EDEmanuela D'Acunto
Emanuela D'Acunto
AFAnnamaria Fra
Annamaria Fra

27 February 2024 in Clinical Chemistry and Laboratory Medicine (CCLM)
Verified
Journal Article
Closed access
ABAlice Balderacchi
Alice Balderacchi
MBMattia Bignotti
Mattia Bignotti
SOStefania Ottaviani
Stefania Ottaviani
ADAndrea Denardo
Andrea Denardo
VBValentina Barzon
Valentina Barzon
AFAnnamaria Fra
Annamaria Fra
Objectives: Alpha-1-antitrypsin deficiency is a genetic disorder caused by mutations in the SERPINA1 gene encoding alpha-1-antitrypsin (AAT), the major serine protease inhibitor in plasma. Reduced AAT levels are associated with elevated risk of developing emphysema mainly due to uncontrolled activity of neutrophil elastase in the lungs. The prevalent Z-AAT mutant and many rare pathogenic AAT variants also predispose to liver disease due to their accumulation as polymeric chains in hepatocytes. Part of these polymers are secreted into the bloodstream and could represent biomarkers of intra-hepatic accumulation. Moreover, being inactive, they further lower lung protection against proteases. Aim of our study is to accurately quantify the percentage of circulating polymers (CP) in a cohort of subjects with different SERPINA1 genotypes. Methods: CP concentration was measured in plasma or Dried Blood Spot (DBS) by a sensitive sandwich ELISA based on capture by the polymer-specific 2C1 monoclonal antibody. Results: CP were significantly elevated in patients with the prevalent PI*SZ and PI*ZZ genotypes, with considerable intra-genotype variability. Notably, higher percentage of polymers was observed in association with elevated C-reactive protein. CP levels were also increased in carriers of the Mmalton variant, and of Mprocida, I, Plowell and Mherleen in heterozygosity with Z-AAT. Conclusions: These findings highlight the importance of implementing CP quantification in a clinical laboratory. Indeed, the variable amount of CP in patients with the same genotype may correlate with the variable severity of the associated lung and liver diseases. Moreover, CP can reveal the polymerogenic potential of newly discovered ultrarare AAT variants.

Verified
Journal Article
Open access
PDF file
EKEmna Ben Khlifa
Emna Ben Khlifa
ACAlessia Campese
Alessia Campese
Andrea CorsiAndrea Corsi
Andrea Corsi
CBCristina Bombieri
Cristina Bombieri
Maria RomanelliMaria Romanelli
Maria Romanelli
ARAlessandra Ruggiero
Alessandra Ruggiero
Post-translational modifications (PTMs) are crucial chemical alterations occurring on proteins post-synthesis, impacting various cellular processes. During viral infections, PTMs are shown to play a multitude of roles in viral replication, host interaction, and immune evasion. Thus, these modifications can influence infectivity, with direct impact on the anti-viral host immune responses and potentially viral adaptation across species. This field is still scarcely explored, whilst understanding PTMs is not only important to advance the knowledge of virus pathology but also potentially to provide insights for vaccine development. In this review, we attempt to summarize the latest findings mainly published over the last 10 years, focusing on the roles of PTMs involved in virus infection and anti-viral immune responses, in the context of relevant human respiratory infections: influenza A virus (IAV), respiratory syncytial virus (RSV), and SARS-CoV-2. We decided to concentrate on these three viruses because they currently represent a global health problem due to recurrent outbreaks and pandemic potential. A deeper characterization of the PTMs may help in understanding virus–host interaction with possible implications on curative strategies. Further, we will report on cutting-edge technologies to study in vitro virus infection in different cellular-based systems. In particular, we describe and discuss the application of 2D and 3D lung organoid cell-culture systems as in vitro models to mimic respiratory environments and to study the PTMs in a controlled setting. Finally, we will discuss the importance of PTMs in the context of next-generation vaccine design, especially for their potential role to offer effective protection against respiratory viruses.